NIH Grant Writing Tips 101 by Darrin Akins
Friday, April 13, 2012
OK EPSCoR NSF Grants Workshop Presentation by Dr. Darrin Akins, "NIH Grant Writing Tips: 101"
About the Author:
Dr. Darrin Akins is a Presidential Professor in the Department of Microbiology & Immunology at the Oklahoma University Health Sciences Center (OUHSC). Dr. Akins has been funded by the NIH since arriving at OUHSC and currently is Principal Investigator on several NIH grant awards. He is the Principal Investigator of the statewide Oklahoma IDeA Network of Biomedical Research Excellence (INBRE) award, which is the single largest NIH grant in the state of OK (~$20 million). He has served as a permanent member of the American Heart Association Immunology and Microbiology study section for four years and also was a permanent member of the Microbiology and Infectious Disease Research Committee (MID) study section at NIH for five years. Dr. Akins also has served ad hoc on several other NIH study sections, including the NIH underrepresented minority predoctoral fellowship study section. He also is a member of the Infection & Immunity and Frontiers in Microbiology editorial boards. Dr. Akins has extensive administrative experience and was the Graduate College Assistant Dean at OUHSC from 2006 - 2011, where he was in charge of directing all summer undergraduate research programs on the OUHSC campus. Dr. Akins is currently the Associate Dean for Research in the College of Medicine at OUHSC.
Dr. Akins’ also is Principal Investigator on four different research grant awards and runs a highly productive research laboratory at OUHSC. Two of the grant awards are from the NIH (one R01 and one R21), one is from OCAST, and the last is from a diagnostic biotechnology company. His research focus is on Lyme disease, the most common tick-borne infection in the United States. The major goal of his laboratory research is to identify proteins from the organism that causes Lyme disease and examine their role with regard to virulence, diagnostic testing, and vaccine development for this debilitating disease.
Presentation File(s):
